Birdwatch Note
2024-08-17 22:09:17 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
At a '19 campaign stop, a diabetic man asked about lowering insulin costs. KH proposed taking the patents of federally funded drug companies that wouldn't submit to price controls. She proposes basing prices on the average worldwide cost of any given drug (28:30-34 min mark). https://www.c-span.org/video/?c5128536/user-clip-rd-patents
Written by 3743401D2CCC3AC9C273905B45169229FCEF4B411F88B953082C047FD422F8A4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1824661827156107676
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1824931531036475658
- noteId - 1824931531036475658
- participantId -
- noteAuthorParticipantId - 3743401D2CCC3AC9C273905B45169229FCEF4B411F88B953082C047FD422F8A4
- createdAtMillis - 1723932557246
- tweetId - 1824661827156107676
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- At a '19 campaign stop, a diabetic man asked about lowering insulin costs. KH proposed taking the patents of federally funded drug companies that wouldn't submit to price controls. She proposes basing prices on the average worldwide cost of any given drug (28:30-34 min mark). https://www.c-span.org/video/?c5128536/user-clip-rd-patents
Note Ratings
| rated at | rated by | |
| 2024-08-24 17:02:04 -0500 | Rating Details | |
| 2024-08-19 10:49:01 -0500 | Rating Details | |
| 2024-08-18 16:58:42 -0500 | Rating Details | |
| 2024-08-18 14:12:43 -0500 | Rating Details | |
| 2024-08-18 13:21:20 -0500 | Rating Details | |
| 2024-08-18 12:54:31 -0500 | Rating Details | |
| 2024-08-18 12:09:09 -0500 | Rating Details | |
| 2024-08-18 10:56:01 -0500 | Rating Details | |
| 2024-08-18 08:14:27 -0500 | Rating Details | |
| 2024-08-18 08:07:50 -0500 | Rating Details | |
| 2024-08-18 06:37:07 -0500 | Rating Details | |
| 2024-08-18 04:38:35 -0500 | Rating Details | |
| 2024-08-18 03:04:38 -0500 | Rating Details | |
| 2024-08-17 22:14:18 -0500 | Rating Details | |
| 2024-08-17 22:00:22 -0500 | Rating Details | |
| 2024-08-17 21:26:30 -0500 | Rating Details | |
| 2024-08-17 20:34:44 -0500 | Rating Details | |
| 2024-08-17 19:25:54 -0500 | Rating Details | |
| 2024-08-17 19:09:21 -0500 | Rating Details | |
| 2024-08-17 18:14:54 -0500 | Rating Details | |
| 2024-08-17 17:38:10 -0500 | Rating Details | |
| 2024-08-17 17:16:00 -0500 | Rating Details | |
| 2024-08-19 14:16:17 -0500 | Rating Details | |
| 2024-08-19 04:50:23 -0500 | Rating Details | |
| 2024-08-18 17:58:03 -0500 | Rating Details | |
| 2024-08-18 17:12:26 -0500 | Rating Details | |
| 2024-08-18 12:13:55 -0500 | Rating Details | |
| 2024-08-18 11:49:00 -0500 | Rating Details | |
| 2024-08-18 11:38:01 -0500 | Rating Details | |
| 2024-08-18 11:37:47 -0500 | Rating Details | |
| 2024-08-18 09:11:17 -0500 | Rating Details | |
| 2024-08-18 02:28:46 -0500 | Rating Details | |
| 2024-08-18 00:02:49 -0500 | Rating Details | |
| 2024-08-17 21:04:52 -0500 | Rating Details | |
| 2024-08-17 20:51:32 -0500 | Rating Details | |
| 2024-08-17 18:31:49 -0500 | Rating Details | |
| 2024-08-17 18:21:05 -0500 | Rating Details |